Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Nov;55(11):3119-3125.
doi: 10.1002/ppul.25004. Epub 2020 Aug 13.

Persistent tachypnea of infancy: Follow up at school age

Affiliations

Persistent tachypnea of infancy: Follow up at school age

Elias Seidl et al. Pediatr Pulmonol. 2020 Nov.

Abstract

Background: Persistent tachypnea of infancy (PTI) is a rare pediatric lung disease of unknown origin. The diagnosis can be made by clinical presentation and chest high resolution computed tomography after exclusion of other causes. Clinical courses beyond infancy have rarely been assessed.

Methods: Patients included in the Kids Lung Register diagnosed with PTI as infants and now older than 5 years were identified. Initial presentation, extrapulmonary comorbidities, spirometry and clinical outcome were analyzed.

Results: Thirty-five children older than 5 years with PTI diagnosed as infants were analyzed. At the age of 5 years, 74% of the patients were reported as asymptomatic and did not develope new symptoms during the observational period at school-age (mean, 3.9 years; range, 0.3-6.3). At the age of about 10 years, none of the symptomatic children had abnormal oxygen saturation during sleep or exercise anymore. Lung function tests and breathing frequency were within normal values throughout the entire observational period.

Conclusions: PTI is a pulmonary disease that can lead to respiratory insufficiency in infancy. As at school age most of the previously chronically affected children became asymptomatic and did not develop new symptoms. We conclude that the overall clinical course is favorable.

Keywords: children's interstitial lung disease; lung function test; neuroendocrine cell hyperplasia of infancy; pulmonary function test; rare diseases.

PubMed Disclaimer

References

REFERENCES

    1. Kurland G, Deterding RR, Hagood JS, et al. An official American Thoracic Society clinical practice guideline: classification, evaluation, and management of childhood interstitial lung disease in infancy. Am J Respir Crit Care Med. 2013;188:376-394. https://doi.org/10.1164/rccm.201305-0923ST
    1. Deutsch GH, Young LR, Deterding RR, et al. Diffuse lung disease in young children: application of a novel classification scheme. Am J Respir Crit Care Med. 2007;176:1120-1128. https://doi.org/10.1164/rccm.200703-393OC
    1. Das S, Langston C, Fan LL. Interstitial lung disease in children. Curr Opin Pediatr. 2011;23:325-331. https://doi.org/10.1097/MOP.0b013e3283464a37
    1. Griese M, Haug M, Brasch F, et al. Incidence and classification of pediatric diffuse parenchymal lung diseases in Germany. Orphanet J Rare Dis. 2009;4:26. https://doi.org/10.1186/1750-1172-4-26
    1. Kornum JB, Christensen S, Grijota M, et al. The incidence of interstitial lung disease 1995-2005: a Danish nationwide population-based study. BMC Pulm Med. 2008;8:24. https://doi.org/10.1186/1471-2466-8-24

Publication types